Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options von Jacobson, Ira M, Gordon, Stuart C, Kowdley, Kris V, Yoshida, Eric M, Rodriguez-Torres, Maribel, Sulkowski, Mark S, Shiffman, Mitchell L, Lawitz, Eric, Everson, Gregory, Bennett, Michael, Schiff, Eugene, Al-Assi, M. Tarek, Subramanian, G. Mani, An, Di, Lin, Ming, McNally, John, Brainard, Diana, Symonds, William T, McHutchison, John G, Patel, Keyur, Feld, Jordan, Pianko, Stephen, Nelson, David R

Volltext

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection von Sulkowski, Mark S, Gardiner, David F, Rodriguez-Torres, Maribel, Reddy, K. Rajender, Hassanein, Tarek, Jacobson, Ira, Lawitz, Eric, Lok, Anna S, Hinestrosa, Federico, Thuluvath, Paul J, Schwartz, Howard, Nelson, David R, Everson, Gregory T, Eley, Timothy, Wind-Rotolo, Megan, Huang, Shu-Pang, Gao, Min, Hernandez, Dennis, McPhee, Fiona, Sherman, Diane, Hindes, Robert, Symonds, William, Pasquinelli, Claudio, Grasela, Dennis M

Volltext

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection von Lawitz, Eric, Mangia, Alessandra, Wyles, David, Rodriguez-Torres, Maribel, Hassanein, Tarek, Gordon, Stuart C, Schultz, Michael, Davis, Mitchell N, Kayali, Zeid, Reddy, K. Rajender, Jacobson, Ira M, Kowdley, Kris V, Nyberg, Lisa, Subramanian, G. Mani, Hyland, Robert H, Arterburn, Sarah, Jiang, Deyuan, McNally, John, Brainard, Diana, Symonds, William T, McHutchison, John G, Sheikh, Aasim M, Younossi, Zobair, Gane, Edward J

Volltext

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials von Anstee, Quentin M., Lawitz, Eric J., Alkhouri, Naim, Wong, Vincent Wai‐Sun, Romero‐Gomez, Manuel, Okanoue, Takeshi, Trauner, Michael, Kersey, Kathryn, Li, Georgia, Han, Ling, Jia, Catherine, Wang, Lulu, Chen, Guang, Subramanian, G. Mani, Myers, Robert P., Djedjos, C. Stephen, Kohli, Anita, Bzowej, Natalie, Younes, Ziad, Sarin, Shiv, Shiffman, Mitchell L., Harrison, Stephen A., Afdhal, Nezam H., Goodman, Zachary, Younossi, Zobair M.

Volltext

Treatment of HCV Infection by Targeting MicroRNA von Janssen, Harry L.A, Reesink, Hendrik W, Lawitz, Eric J, Zeuzem, Stefan, Rodriguez-Torres, Maribel, Patel, Keyur, van der Meer, Adriaan J, Patick, Amy K, Chen, Alice, Zhou, Yi, Persson, Robert, King, Barney D, Kauppinen, Sakari, Levin, Arthur A, Hodges, Michael R

Volltext

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2... von Sanyal, Arun, Charles, Edgar D, Neuschwander-Tetri, Brent A, Loomba, Rohit, Harrison, Stephen A, Abdelmalek, Manal F, Lawitz, Eric J, Halegoua-DeMarzio, Dina, Kundu, Sudeep, Noviello, Stephanie, Luo, Yi, Christian, Rose

Volltext

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR... von Lawitz, Eric, Prof, Poordad, Fred F, Prof, Pang, Phillip S, MD, Hyland, Robert H, DPhil, Ding, Xiao, PhD, Mo, Hongmei, PhD, Symonds, William T, PharmD, McHutchison, John G, MD, Membreno, Fernando E, MD

Volltext

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment von Gane, Edward, Lawitz, Eric, Pugatch, David, Papatheodoridis, Georgios, Bräu, Norbert, Brown, Ashley, Pol, Stanislas, Leroy, Vincent, Persico, Marcello, Moreno, Christophe, Colombo, Massimo, Yoshida, Eric M, Nelson, David R, Collins, Christine, Lei, Yang, Kosloski, Matthew, Mensa, Federico J

Volltext

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients von Pockros, Paul J., Fuchs, Michael, Freilich, Bradley, Schiff, Eugene, Kohli, Anita, Lawitz, Eric J., Hellstern, Paul A., Owens‐Grillo, Janet, Van Biene, Courtney, Shringarpure, Reshma, MacConell, Leigh, Shapiro, David, Cohen, David E.

Volltext

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 von Lok, Anna S, Gardiner, David F, Lawitz, Eric, Martorell, Claudia, Everson, Gregory T, Ghalib, Reem, Reindollar, Robert, Rustgi, Vinod, McPhee, Fiona, Wind-Rotolo, Megan, Persson, Anna, Zhu, Kurt, Dimitrova, Dessislava I, Eley, Timothy, Guo, Tong, Grasela, Dennis M, Pasquinelli, Claudio

Volltext

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1 von Kowdley, Kris V, Lawitz, Eric, Poordad, Fred, Cohen, Daniel E, Nelson, David R, Zeuzem, Stefan, Everson, Gregory T, Kwo, Paul, Foster, Graham R, Sulkowski, Mark S, Xie, Wangang, Pilot-Matias, Tami, Liossis, George, Larsen, Lois, Khatri, Amit, Podsadecki, Thomas, Bernstein, Barry

Volltext

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease von Loomba, Rohit, Kayali, Zeid, Noureddin, Mazen, Ruane, Peter, Lawitz, Eric J., Bennett, Michael, Wang, Lulu, Harting, Eliza, Tarrant, Jacqueline M., McColgan, Bryan J., Chung, Chuhan, Ray, Adrian S., Subramanian, G. Mani, Myers, Robert P., Middleton, Michael S., Lai, Michelle, Charlton, Michael, Harrison, Stephen A.

Volltext

Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial von Patel, Keyur, Harrison, Stephen A., Elkhashab, Magdy, Trotter, James F., Herring, Robert, Rojter, Sergio E., Kayali, Zeid, Wong, Vincent Wai‐Sun, Greenbloom, Susan, Jayakumar, Saumya, Shiffman, Mitchell L., Freilich, Bradley, Lawitz, Eric J., Gane, Edward J., Harting, Eliza, Xu, Jun, Billin, Andrew N., Chung, Chuhan, Djedjos, C. Stephen, Subramanian, G. Mani, Myers, Robert P., Middleton, Michael S., Rinella, Mary, Noureddin, Mazen

Volltext

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis von Harrison, Stephen A., Abdelmalek, Manal F., Caldwell, Stephen, Shiffman, Mitchell L., Diehl, Anna Mae, Ghalib, Reem, Lawitz, Eric J., Rockey, Don C., Schall, Raul Aguilar, Jia, Catherine, McColgan, Bryan J., McHutchison, John G., Subramanian, G. Mani, Myers, Robert P., Younossi, Zobair, Ratziu, Vlad, Muir, Andrew J., Afdhal, Nezam H., Goodman, Zachary, Bosch, Jaime, Sanyal, Arun J.

Volltext

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis von Curry, Michael P, O’Leary, Jacqueline G, Bzowej, Natalie, Muir, Andrew J, Korenblat, Kevin M, Fenkel, Jonathan M, Reddy, K. Rajender, Lawitz, Eric, Flamm, Steven L, Schiano, Thomas, Teperman, Lewis, Fontana, Robert, Schiff, Eugene, Fried, Michael, Doehle, Brian, An, Di, McNally, John, Osinusi, Anu, Brainard, Diana M, McHutchison, John G, Brown, Robert S, Charlton, Michael

Volltext

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis von Sanyal, Arun J., Ratziu, Vlad, Loomba, Rohit, Anstee, Quentin M., Kowdley, Kris V., Rinella, Mary E., Sheikh, Muhammad Y., Trotter, James F., Knapple, Whitfield, Lawitz, Eric J., Abdelmalek, Manal F., Newsome, Philip N., Boursier, Jérôme, Mathurin, Philippe, Dufour, Jean-François, Berrey, M. Michelle, Shiff, Steven J., Sawhney, Sangeeta, Capozza, Thomas, Leyva, Rina, Harrison, Stephen A., Younossi, Zobair M.

Volltext

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis von Loomba, Rohit, Hartman, Mark L., Lawitz, Eric J., Vuppalanchi, Raj, Boursier, Jérôme, Bugianesi, Elisabetta, Yoneda, Masato, Behling, Cynthia, Cummings, Oscar W., Tang, Yuanyuan, Brouwers, Bram, Robins, Deborah A., Nikooie, Amir, Bunck, Mathijs C., Haupt, Axel, Sanyal, Arun J.

Volltext

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis von Lawitz, Eric J., Coste, Angie, Poordad, Fred, Alkhouri, Naim, Loo, Nicole, McColgan, Bryan J., Tarrant, Jacqueline M., Nguyen, Tuan, Han, Ling, Chung, Chuhan, Ray, Adrian S., McHutchison, John G., Subramanian, G. Mani, Myers, Robert P., Middleton, Michael S., Sirlin, Claude, Loomba, Rohit, Nyangau, Edna, Fitch, Mark, Li, Kelvin, Hellerstein, Marc

Volltext

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT... von Kwo, Paul Y, Dr, Lawitz, Eric J, MD, McCone, Jonathan, MD, Schiff, Eugene R, Prof, Vierling, John M, Prof, Pound, David, MD, Davis, Mitchell N, DO, Galati, Joseph S, MD, Gordon, Stuart C, MD, Ravendhran, Natarajan, MD, Rossaro, Lorenzo, Prof, Anderson, Frank H, MD, Jacobson, Ira M, Prof, Rubin, Raymond, MD, Koury, Kenneth, PhD, Pedicone, Lisa D, PhD, Brass, Clifford A, MD, Chaudhri, Eirum, MD, Albrecht, Janice K, PhD

Volltext

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection von Afdhal, Nezam, Reddy, K. Rajender, Nelson, David R, Lawitz, Eric, Gordon, Stuart C, Schiff, Eugene, Nahass, Ronald, Ghalib, Reem, Gitlin, Norman, Herring, Robert, Lalezari, Jacob, Younes, Ziad H, Pockros, Paul J, Di Bisceglie, Adrian M, Arora, Sanjeev, Subramanian, G. Mani, Zhu, Yanni, Dvory-Sobol, Hadas, Yang, Jenny C, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Sulkowski, Mark, Kwo, Paul

Volltext